First Header Logo Second Header Logo

Connection

Haodong Xu to Animals

This is a "connection" page, showing publications Haodong Xu has written about Animals.
Connection Strength

0.748
  1. Zhao L, You T, Lu Y, Lin S, Li F, Xu H. Elevated EZH2 in ischemic heart disease epigenetically mediates suppression of NaV1.5 expression. J Mol Cell Cardiol. 2021 Apr; 153:95-103.
    View in: PubMed
    Score: 0.081
  2. Zhao L, Sun L, Lu Y, Li F, Xu H. A small-molecule LF3 abrogates ß-catenin/TCF4-mediated suppression of NaV1.5 expression in HL-1 cardiomyocytes. J Mol Cell Cardiol. 2019 Oct; 135:90-96.
    View in: PubMed
    Score: 0.074
  3. Huo R, Hu C, Zhao L, Sun L, Wang N, Lu Y, Ye B, Deb A, Li F, Xu H. Enhancement of ß-catenin/T-cell factor 4 signaling causes susceptibility to cardiac arrhythmia by suppressing NaV1.5 expression in mice. Heart Rhythm. 2019 Nov; 16(11):1720-1728.
    View in: PubMed
    Score: 0.073
  4. Wang N, Huo R, Cai B, Lu Y, Ye B, Li X, Li F, Xu H. Activation of Wnt/ß-catenin signaling by hydrogen peroxide transcriptionally inhibits NaV1.5 expression. Free Radic Biol Med. 2016 Jul; 96:34-44.
    View in: PubMed
    Score: 0.059
  5. Cai B, Wang N, Mao W, You T, Lu Y, Li X, Ye B, Li F, Xu H. Deletion of FoxO1 leads to shortening of QRS by increasing Na(+) channel activity through enhanced expression of both cardiac NaV1.5 and ß3 subunit. J Mol Cell Cardiol. 2014 Sep; 74:297-306.
    View in: PubMed
    Score: 0.052
  6. Mao W, You T, Ye B, Li X, Dong HH, Hill JA, Li F, Xu H. Reactive oxygen species suppress cardiac NaV1.5 expression through Foxo1. PLoS One. 2012; 7(2):e32738.
    View in: PubMed
    Score: 0.044
  7. Lu Z, Abe J, Taunton J, Lu Y, Shishido T, McClain C, Yan C, Xu SP, Spangenberg TM, Xu H. Reactive oxygen species-induced activation of p90 ribosomal S6 kinase prolongs cardiac repolarization through inhibiting outward K+ channel activity. Circ Res. 2008 Aug 01; 103(3):269-78.
    View in: PubMed
    Score: 0.034
  8. Hu CC, Wei X, Liu JM, Han LL, Xia CK, Wu J, You T, Zhu AF, Yao SL, Yuan SY, Xu HD, Xia ZY, Wang TT, Mao WK. Cardiac-targeted PIASy gene silencing mediates deSUMOylation of caveolin-3 and prevents ischemia/reperfusion-induced Nav1.5 downregulation and ventricular arrhythmias. Mil Med Res. 2022 Oct 14; 9(1):58.
    View in: PubMed
    Score: 0.023
  9. Wang P, Xu S, Xu J, Xin Y, Lu Y, Zhang H, Zhou B, Xu H, Sheu SS, Tian R, Wang W. Elevated MCU Expression by CaMKIIdB Limits Pathological Cardiac Remodeling. Circulation. 2022 Apr 05; 145(14):1067-1083.
    View in: PubMed
    Score: 0.022
  10. Xu H, Barry DM, Li H, Brunet S, Guo W, Nerbonne JM. Attenuation of the slow component of delayed rectification, action potential prolongation, and triggered activity in mice expressing a dominant-negative Kv2 alpha subunit. Circ Res. 1999 Oct 01; 85(7):623-33.
    View in: PubMed
    Score: 0.019
  11. Xu H, Li H, Nerbonne JM. Elimination of the transient outward current and action potential prolongation in mouse atrial myocytes expressing a dominant negative Kv4 alpha subunit. J Physiol. 1999 Aug 15; 519 Pt 1(Pt 1):11-21.
    View in: PubMed
    Score: 0.018
  12. Xu H, Guo W, Nerbonne JM. Four kinetically distinct depolarization-activated K+ currents in adult mouse ventricular myocytes. J Gen Physiol. 1999 May; 113(5):661-78.
    View in: PubMed
    Score: 0.018
  13. Ye B, Li L, Xu H, Chen Y, Li F. Opposing roles of TCF7/LEF1 and TCF7L2 in cyclin D2 and Bmp4 expression and cardiomyocyte cell cycle control during late heart development. Lab Invest. 2019 Jun; 99(6):807-818.
    View in: PubMed
    Score: 0.018
  14. Hou N, Wen Y, Yuan X, Xu H, Wang X, Li F, Ye B. Activation of Yap1/Taz signaling in ischemic heart disease and dilated cardiomyopathy. Exp Mol Pathol. 2017 Dec; 103(3):267-275.
    View in: PubMed
    Score: 0.016
  15. Zhu A, Wei X, Zhang Y, You T, Yao S, Yuan S, Xu H, Li F, Mao W. Propofol Provides Cardiac Protection by Suppressing the Proteasome Degradation of Caveolin-3 in Ischemic/Reperfused Rat Hearts. J Cardiovasc Pharmacol. 2017 Mar; 69(3):170-177.
    View in: PubMed
    Score: 0.016
  16. Xu H, Dixon JE, Barry DM, Trimmer JS, Merlie JP, McKinnon D, Nerbonne JM. Developmental analysis reveals mismatches in the expression of K+ channel alpha subunits and voltage-gated K+ channel currents in rat ventricular myocytes. J Gen Physiol. 1996 Nov; 108(5):405-19.
    View in: PubMed
    Score: 0.015
  17. Hou N, Ye B, Li X, Margulies KB, Xu H, Wang X, Li F. Transcription Factor 7-like 2 Mediates Canonical Wnt/ß-Catenin Signaling and c-Myc Upregulation in Heart Failure. Circ Heart Fail. 2016 Jun; 9(6).
    View in: PubMed
    Score: 0.015
  18. Ye B, Hou N, Xiao L, Xu Y, Xu H, Li F. Dynamic monitoring of oxidative DNA double-strand break and repair in cardiomyocytes. Cardiovasc Pathol. 2016; 25(2):93-100.
    View in: PubMed
    Score: 0.014
  19. Ye B, Hou N, Xiao L, Xu Y, Boyer J, Xu H, Li F. APC controls asymmetric Wnt/ß-catenin signaling and cardiomyocyte proliferation gradient in the heart. J Mol Cell Cardiol. 2015 Dec; 89(Pt B):287-96.
    View in: PubMed
    Score: 0.014
  20. Guo J, Yao H, Lin X, Xu H, Dean D, Zhu Z, Liu G, Sime P. IL-13 induces YY1 through the AKT pathway in lung fibroblasts. PLoS One. 2015; 10(3):e0119039.
    View in: PubMed
    Score: 0.014
  21. Le NT, Heo KS, Takei Y, Lee H, Woo CH, Chang E, McClain C, Hurley C, Wang X, Li F, Xu H, Morrell C, Sullivan MA, Cohen MS, Serafimova IM, Taunton J, Fujiwara K, Abe J. A crucial role for p90RSK-mediated reduction of ERK5 transcriptional activity in endothelial dysfunction and atherosclerosis. Circulation. 2013 Jan 29; 127(4):486-99.
    View in: PubMed
    Score: 0.012
  22. Lim JH, Jono H, Komatsu K, Woo CH, Lee J, Miyata M, Matsuno T, Xu X, Huang Y, Zhang W, Park SH, Kim YI, Choi YD, Shen H, Heo KS, Xu H, Bourne P, Koga T, Xu H, Yan C, Wang B, Chen LF, Feng XH, Li JD. CYLD negatively regulates transforming growth factor-ß-signalling via deubiquitinating Akt. Nat Commun. 2012 Apr 10; 3:771.
    View in: PubMed
    Score: 0.011
  23. Lin X, Sime PJ, Xu H, Williams MA, LaRussa L, Georas SN, Guo J. Yin yang 1 is a novel regulator of pulmonary fibrosis. Am J Respir Crit Care Med. 2011 Jun 15; 183(12):1689-97.
    View in: PubMed
    Score: 0.010
  24. Miller CL, Oikawa M, Cai Y, Wojtovich AP, Nagel DJ, Xu X, Xu H, Florio V, Rybalkin SD, Beavo JA, Chen YF, Li JD, Blaxall BC, Abe J, Yan C. Role of Ca2+/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy. Circ Res. 2009 Nov 06; 105(10):956-64.
    View in: PubMed
    Score: 0.009
  25. Lim JH, Jono H, Koga T, Woo CH, Ishinaga H, Bourne P, Xu H, Ha UH, Xu H, Li JD. Tumor suppressor CYLD acts as a negative regulator for non-typeable Haemophilus influenza-induced inflammation in the middle ear and lung of mice. PLoS One. 2007 Oct 10; 2(10):e1032.
    View in: PubMed
    Score: 0.008
  26. Lim JH, Stirling B, Derry J, Koga T, Jono H, Woo CH, Xu H, Bourne P, Ha UH, Ishinaga H, Xu H, Andalibi A, Feng XH, Zhu H, Huang Y, Zhang W, Weng X, Yan C, Yin Z, Briles DE, Davis RJ, Flavell RA, Li JD. Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections. Immunity. 2007 Aug; 27(2):349-60.
    View in: PubMed
    Score: 0.008
  27. Yan C, Ding B, Shishido T, Woo CH, Itoh S, Jeon KI, Liu W, Xu H, McClain C, Molina CA, Blaxall BC, Abe J. Activation of extracellular signal-regulated kinase 5 reduces cardiac apoptosis and dysfunction via inhibition of a phosphodiesterase 3A/inducible cAMP early repressor feedback loop. Circ Res. 2007 Mar 02; 100(4):510-9.
    View in: PubMed
    Score: 0.008
  28. Bhagwat SP, Gigliotti F, Xu H, Wright TW. Contribution of T cell subsets to the pathophysiology of Pneumocystis-related immunorestitution disease. Am J Physiol Lung Cell Mol Physiol. 2006 Dec; 291(6):L1256-66.
    View in: PubMed
    Score: 0.007
  29. Guo W, Jung WE, Marionneau C, Aimond F, Xu H, Yamada KA, Schwarz TL, Demolombe S, Nerbonne JM. Targeted deletion of Kv4.2 eliminates I(to,f) and results in electrical and molecular remodeling, with no evidence of ventricular hypertrophy or myocardial dysfunction. Circ Res. 2005 Dec 09; 97(12):1342-50.
    View in: PubMed
    Score: 0.007
  30. Ding B, Abe J, Wei H, Xu H, Che W, Aizawa T, Liu W, Molina CA, Sadoshima J, Blaxall BC, Berk BC, Yan C. A positive feedback loop of phosphodiesterase 3 (PDE3) and inducible cAMP early repressor (ICER) leads to cardiomyocyte apoptosis. Proc Natl Acad Sci U S A. 2005 Oct 11; 102(41):14771-6.
    View in: PubMed
    Score: 0.007
  31. Chiu HC, Kovacs A, Blanton RM, Han X, Courtois M, Weinheimer CJ, Yamada KA, Brunet S, Xu H, Nerbonne JM, Welch MJ, Fettig NM, Sharp TL, Sambandam N, Olson KM, Ory DS, Schaffer JE. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. Circ Res. 2005 Feb 04; 96(2):225-33.
    View in: PubMed
    Score: 0.007
  32. Li H, Guo W, Xu H, Hood R, Benedict AT, Nerbonne JM. Functional expression of a GFP-tagged Kv1.5 alpha-subunit in mouse ventricle. Am J Physiol Heart Circ Physiol. 2001 Nov; 281(5):H1955-67.
    View in: PubMed
    Score: 0.005
  33. Guo W, Xu H, London B, Nerbonne JM. Molecular basis of transient outward K+ current diversity in mouse ventricular myocytes. J Physiol. 1999 Dec 15; 521 Pt 3(Pt 3):587-99.
    View in: PubMed
    Score: 0.005
  34. Barry DM, Xu H, Schuessler RB, Nerbonne JM. Functional knockout of the transient outward current, long-QT syndrome, and cardiac remodeling in mice expressing a dominant-negative Kv4 alpha subunit. Circ Res. 1998 Sep 07; 83(5):560-7.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.